Healthcare - Biotechnology - NASDAQ - US
$ 4.065
-17.2 %
$ 398 M
Market Cap
-2.38
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
101.87%
EBIT
Estimate
--72.63%
Net Income
Estimate
65.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alector, Inc.
ALEC has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ALEC
EBIT FORECAST
EBIT Forecast Chart ALEC
NET INCOME FORECAST
Net Income Chart ALEC